Year: 2015
Type: dissertation
Abstract: Tyrosine kinase inhibitors (TKIs) developed for the treatment of cancer were reported to have a protective and beneficial effect in diabetic patients, which manifested in improved glycemic control and insulin sensitivity, favorable regulation of lipid metabolism and increased insulin secretion. We found that the TKI sunitinib increased insulin secretion in beta cells. Based on this observation we assembled a library of TKI and TKI-like compounds then performed a phenotypic screen looking for candidates exerting insulinotropic effects. We found some compounds that were less toxic and more selective than sunitinib. Furthermore we could also identify some of their targets and supposed mechanism of action.
Source: MPG.PuRe (Max Planck Society)
Author: Zoltán Őrfi
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2753190296
